The Bcl-2 inhibitor ABT-263 enhances the response of multiple chemotherapeutic regimens in hematologic tumors in vivo
Scott Ackler; Michael J. Mitten; Kelly Foster; Anatol Oleksijew; Marion Refici; Stephen K. Tahir; Yu Xiao; Christin Tse; David J. Frost; Stephen W. Fesik; Saul H. Rosenberg; Steven W. Elmore; Alexander R. Shoemaker
- 作者Scott Ackler; Michael J. Mitten; Kelly Foster; Anatol Oleksijew; Marion Refici; Stephen K. Tahir; Yu Xiao; Christin Tse; David J. Frost; Stephen W. Fesik; Saul H. Rosenberg; Steven W. Elmore; Alexander R. Shoemaker
- 卷第66卷
- 期第5期
- 印刷ISSN0344-5704
- 电子ISSN1432-0843
- 文件大小682.66KB
- 发表时间2010-10
- DOI10.1007/s00280-009-1232-1
- 页码869-880